Maria Papandreou | Health Professions | Best Researcher Award

Published on by Award and Honors

Best Researcher Award

Maria Papandreou
University of West Attika, Greece

Maria Papandreou
Affiliation University of West Attika
Country Greece
Scopus ID 8964296200
Documents 52
Citations 815
h-index 12
Subject Area Health Professions
Event International Award and Honors
ORCID 0000-0002-0415-0546

Maria Papandreou is a researcher affiliated with the University of West Attika whose scholarly work contributes to the fields of rehabilitation sciences, physiotherapy, musculoskeletal health, exercise intervention, and sports medicine. Her publication record demonstrates sustained engagement with evidence-based clinical practice and the evaluation of functional outcomes among diverse populations. Through peer-reviewed studies addressing pain management, movement assessment, balance, quality of life, and athletic performance, she has contributed to the advancement of contemporary health professions research.[1]

Abstract

This article presents an overview of the academic profile and research achievements of Maria Papandreou. Her body of work encompasses clinical rehabilitation, sports performance assessment, musculoskeletal disorders, and exercise-based therapeutic interventions. Through methodological studies and applied clinical investigations, her research supports evidence-based decision-making within health professions and contributes to improved patient outcomes and functional performance.[2]

Keywords

Physiotherapy, Rehabilitation Sciences, Sports Medicine, Musculoskeletal Health, Functional Movement, Dynamic Balance, Quality of Life Assessment, Motor Imagery, Clinical Research, Exercise Therapy.

Introduction

The growing importance of rehabilitation and preventive healthcare has increased demand for rigorous clinical research addressing physical function, pain management, and movement optimization. Maria Papandreou’s academic contributions align with these priorities by examining interventions that enhance mobility, performance, and quality of life among both clinical and athletic populations.[3]

Research Profile

With 52 indexed publications, 815 citations, and an h-index of 12, Maria Papandreou has established a recognized research presence within Health Professions. Her work frequently investigates physical rehabilitation outcomes, movement assessment tools, musculoskeletal pain conditions, and evidence-based exercise interventions. The breadth of her publications demonstrates interdisciplinary engagement across physiotherapy, kinesiology, and sports science.[1]

Research Contributions

  • Investigation of active release techniques for reducing delayed-onset muscle soreness among football athletes.[2]
  • Evaluation of lumbar spine stabilization exercises and their effects on functional movement and balance.[3]
  • Assessment of motor imagery ability and perspective among professional football players.[4]
  • Clinical studies addressing rotator cuff-related shoulder pain and rehabilitation strategies.[5]
  • Validation of assessment instruments for patellofemoral pain among Greek patient populations.[6]

Publications

Recent publications include studies published in Healthcare, Applied Sciences, Clinics and Practice, and the Journal of Functional Morphology and Kinesiology. These works address athlete recovery, sedentary lifestyle interventions, motor imagery in sports, shoulder pain management, and psychometric validation of clinical assessment tools. The diversity of topics reflects a commitment to translational healthcare research and practical clinical applications.[2][6]

Research Impact

The citation profile associated with Maria Papandreou’s scholarly output indicates continued engagement by researchers and practitioners in rehabilitation and sports science. Her studies contribute valuable evidence regarding exercise interventions, functional assessment methodologies, and patient-centered therapeutic outcomes. Such contributions support clinical practice development and encourage further investigation within allied health disciplines.[1]

Award Suitability

Maria Papandreou’s research record demonstrates sustained scholarly productivity, measurable citation impact, and contributions to clinically relevant health professions research. Her investigations address contemporary healthcare challenges through scientifically grounded methodologies and practical applications. These characteristics align closely with the objectives of the International Award and Honors program and support consideration for recognition through the Best Researcher Award.[1]

Conclusion

Maria Papandreou represents an active contributor to rehabilitation science and health professions research. Through publications addressing musculoskeletal health, athletic performance, movement assessment, and therapeutic exercise, she has advanced knowledge relevant to clinicians, researchers, and healthcare stakeholders. Her scholarly profile reflects both academic productivity and meaningful engagement with evidence-based healthcare practice.

References

  1. Elsevier. (n.d.). Scopus author details: Maria Papandreou, Author ID 8964296200. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=8964296200
  2. Papandreou, M. et al. (2026). Effects of a Single Session of Active Release Technique on Gastrocnemius Delayed-Onset Muscle Soreness in Male Amateur Football Athletes. Healthcare.
    DOI: https://doi.org/10.3390/healthcare14111581
  3. Papandreou, M. et al. (2026). The Effect of Lumbar Spine Stabilization Exercises on Quality of Life, Functional Movement, and Dynamic Balance. Applied Sciences.
    DOI: https://doi.org/10.3390/app16115432
  4. Papandreou, M. et al. (2025). Motor Imagery Ability and Motor Imagery Perspective Among Professional Football Players. Healthcare.
    DOI: https://doi.org/10.3390/healthcare13233045
  5. Papandreou, M. et al. (2025). Addressing Rotator Cuff-Related Shoulder Pain. Clinics and Practice.
    DOI: https://doi.org/10.3390/clinpract15020030
  6. Papandreou, M. et al. (2025). Reliability and Validity Measures of the Patellofemoral Subscale KOOS-PF in Greek Patients with Patellofemoral Pain. Journal of Functional Morphology and Kinesiology.
    DOI: https://doi.org/10.3390/jfmk10010044

Shebli Atrash | Health Professions | Best Researcher Award

Published on by Award and Honors

Dr. Shebli Atrash | Health Professions | Best Researcher Award 

Dr. Shebli Atrash | Levine Cancer Institute | United States

Dr. Shebli Atrash, MD, MS, FACP, is a distinguished physician-scientist specializing in hematological malignancies and blood disorders. Currently serving as Associate Professor at Wake Forest University School of Medicine, he is deeply committed to advancing cancer research, patient care, and medical education. With an MD from the University of Damascus and advanced training in cancer biology at the University of Arkansas for Medical Sciences, Dr. Atrash has built a career centered on innovation in oncology. His expertise spans clinical practice, academic teaching, translational research, and leadership in clinical trials. Over the years, he has earned multiple recognitions for excellence, including Resident of the Year and awards for top accrual in clinical trials. As a reviewer and editor for leading journals and an active member of numerous professional societies, he continues to shape the global conversation in oncology. His dedication bridges scientific innovation with compassionate patient care.

Professional Profile: 

Scopus

ORCID

Google Scholar

Education

Dr. Atrash began his medical journey at the University of Damascus, where he earned his MD. His pursuit of deeper scientific knowledge led him to the University of Arkansas for Medical Sciences (UAMS), where he completed a Clinical Translational Science Certificate and a Master of Science in Interdisciplinary Biomedical Sciences with a cancer biology track. To complement his clinical and academic expertise, he also completed advanced leadership training through the Physician/APP Leadership Institute program at Atrium Health Levine Cancer Institute and Wake Forest University School of Medicine. His educational path reflects a balance of rigorous medical training, translational research expertise, and leadership development. Each step has prepared him to excel in bridging bedside care with cutting-edge oncology research. His lifelong learning commitment underscores his passion for improving outcomes for patients with hematologic malignancies.

Experience

Dr. Atrash’s professional journey demonstrates a remarkable blend of clinical excellence, academic leadership, and scientific research. He began his training as an Internal Medicine Intern and Resident at St. Barnabas Hospital/Albert Einstein College of Medicine, followed by a Hematology & Oncology Fellowship at UAMS. His faculty appointments span prestigious institutions, including the University of Arkansas for Medical Sciences, University of North Carolina, Atrium Health, and now Wake Forest University School of Medicine, where he serves as an Associate Professor in Hematology and Oncology. Beyond academia, Dr. Atrash has contributed to clinical trial development, serving on multiple advisory boards for leading pharmaceutical companies and acting as a reviewer and editor for top oncology journals. His wide-reaching experience also includes roles on independent review committees for pivotal Phase  clinical trials. With a career marked by leadership, innovation, and collaboration, Dr. Atrash is recognized as both a skilled clinician and a visionary researcher.

Research Interest

Dr. Atrash’s research interests center on hematological malignancies, with a special focus on multiple myeloma. He is deeply engaged in exploring novel therapies and clinical trials that advance patient care, including CAR-T cell therapy, antibody-drug conjugates, and combination regimens for relapsed/refractory myeloma. His translational work integrates cancer cell biology with therapeutic innovation, seeking to develop strategies that improve survival and quality of life for patients. He is currently the Principal Investigator of a multimillion-dollar investigator-initiated trial exploring Carfilzomib, Lenalidomide, Dexamethasone, and Belantamab Mafodotin for multiple myeloma. Additionally, his roles on the International Myeloma Working Group (IMWG), Southwest Oncology Group (SWOG), and CIBMTR reflect his influence on the global hematology research agenda. His interests also extend to improving clinical trial design, translational oncology, and immune-based therapies, positioning him as a leader in shaping the next generation of cancer therapeutics.

Awards

Dr. Atrash has consistently been recognized for his excellence in medicine, research, and clinical trials. Early in his career, he was honored as Resident of the Year at St. Barnabas Hospital. During his time at the University of Arkansas for Medical Sciences, he received the Dean’s Circle of Excellence Awards, highlighting his academic and clinical contributions. More recently, at Atrium Health, he was recognized as the Top Accruer for interventional and non-interventional clinical trials, showcasing his leadership in clinical research and dedication to advancing therapies for patients. These honors reflect his consistent ability to combine academic rigor, research innovation, and patient-centered care. Collectively, they illustrate a career built on excellence, impact, and recognition from both peers and leading institutions in oncology and internal medicine.

Publications

Dr. Atrash has authored and co-authored numerous impactful publications in top-tier oncology and hematology journals. His research spans multiple myeloma, novel therapeutics, and immune-based strategies, with publications widely cited by peers. He also serves as a reviewer, guest editor, and editorial board member for high-impact journals such as Cancers, British Journal of Haematology, and Annals of Blood. Selected publications include:

Title: Dexamethasone for the management of CRS Related to teclistamab in patients with relapsed/refractory multiple myeloma
Citations: 2

Title: Outcomes of teclistamab in patients with relapsed/refractory multiple myeloma with prior exposure to BCMA-directed therapy: a multicenter study from the U.S. Multiple Myeloma Immunotherapy Consortium
Journal: Blood Cancer Journal, 2025

Title: A phase 2 randomized study of modakafusp alfa as a single agent for patients with relapsed/refractory multiple myeloma
Journal: Blood, 2025

Title: Stem Cell Mobilization Yields with Daratumumab (Dara) and Lenalidomide (Len)-Containing Quadruplet Induction Therapy in Patients with Newly Diagnosed Multiple Myeloma (NDMM): A Real-World Experience at 2 Institutes
Journal: Clinical Lymphoma Myeloma and Leukemia, 2025

Title: Teclistamab for patients with heavily pretreated relapsed/refractory multiple myeloma and renal impairment
Journal: Blood Advances, 2025

Title: Global Access to Multiple Myeloma Therapies
Journal: JCO Global Oncology, 2025

Conclusion

Dr. Shebli Atrash is a highly qualified candidate for the Best Researcher Award, bringing together academic excellence, clinical innovation, and impactful service to the hematology and oncology community. His strong record in clinical trial leadership, journal editorships, and advisory roles establishes him as a distinguished researcher in multiple myeloma. With continued growth in authorship leadership, international visibility, and mentorship, Dr. Atrash’s career trajectory promises sustained contributions to cancer research and patient outcomes. Based on his strengths, he is highly suitable for this award.